36944 Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 

Awards Program, National Institutes of 

Health, HHS) 

Dated: July 25, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16299 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Heart, Lung, 

and Blood Advisory Council. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Advisory Council. 

Date: August 28, 2018. 

Time: 1:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Room 9100, Bethesda, MD 

20892 (Teleconference). 

Contact Person: Laura K. Moen, Ph.D., 

Director, Division of Extramural Research 

Activities, National Heart, Lung, and Blood 

Institute, National Institutes of Health, 6701 

Rockledge Drive, Room 7100, Bethesda, MD 

20892, 301–435–0260, moenl@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: 

www.nhlbi.nih.gov/meetings/nhlbac/ 

index.htm, where an agenda and any 

additional information for the meeting will 

be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: July 25, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16293 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Child 

Health and Human Development 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. A 

portion of this meeting will be closed to 

the public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended for the review and 

discussion of grant applications. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the contact person listed below in 

advance of the meeting. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: September 13, 2018–September 14, 

2018. 

Open: September 13, 2018. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, Director’s 

Report, Division of Extramural Research 

Report and other business of the Council. 

Place: National Institutes of Health, 6710B 

Bethesda Drive, Rm. 1425, Bethesda, MD 

20892. 

Closed: September 14, 2018. 

Time: 8:00 a.m. to Adjournment. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6710B 

Bethesda Drive, Rm. 1425, Bethesda, MD 

20892. 

Contact Person: Della Hann, Ph.D., 

Director, Division of Extramural Research, 

Eunice Kenney Shriver National Institute of 

Child Health, and Human Development, NIH, 

6710 Rockledge Blvd., MSC 7002, Bethesda, 

MD 20892, 301–496–8535. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the contact person listed on 

this notice. The statement should include the 

name, address, telephone number, and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxis, hotel, and airport shuttles, 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. In order to facilitate public attendance 

at the open session of Council in the main 

meeting room, Conference Room 1425, please 

contact Ms. Lisa Kaeser, Office of Legislation 

and Public Policy, NICHD, at 301–496–0536 

to make your reservation, additional seating 

will be available in the meeting overflow 

rooms, Conference Rooms 1417 and 1411. 

Individuals will also be able to view the 

meeting via NIH Videocast. Select the 

following link for Videocast access 

instructions: http://www.nichd.nih.gov/ 

about/advisory/nachhd/Pages/virtualmeeting.aspx. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment program, National 

Institutes of Health, HHS) 

Dated: July 25, 2018. 

David D. Clary, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16295 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate requests for 

preclinical development resources for 

potential new therapeutics for the 

treatment of cancer. The outcome of the 

evaluation will provide information to 

internal NCI committees that will 

decide whether NCI should support 

requests and make available contract 

resources for development of the 

potential therapeutic to improve the 

treatment of various forms of cancer. 

The research proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the 


daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 147 / Tuesday, July 31, 2018 / Notices 36945 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; JUN2018 

Cycle 29 NExT SEP Committee Meeting. 

Date: August 30, 2018. 

Time: 8:00 a.m. to 4:30 p.m. 

Agenda: To evaluate the NCI Experimental 

Therapeutics Program Portfolio. 

Place: National Institutes of Health, 9000 

Rockville Pike, Building 31, Wing C, 6th 

Floor, Conference Room 6, Bethesda, MD 

20892. 

Contact Persons: Barbara Mroczkowski, 

Ph.D., Executive Secretary, Discovery 

Experimental Therapeutics Program, 

National Cancer Institute, NIH, 31 Center 

Drive, Room 3A44, Bethesda, MD 20817, 

(301) 496–4291, mroczkoskib@mail.nih.gov. 

Toby Hecht, Ph.D., Executive Secretary, 

Development Experimental Therapeutics 

Program, National Cancer Institute, NIH, 

9609 Medical Center Drive, Room 3W110, 

Rockville, MD 20850, (240) 276–5683, 

toby.hecht2@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: July 25, 2018. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16292 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Mentored Clinical Scientist 

Research Career Development Award (Parent 

K08). 

Date: August 21, 2018. 

Time: 10:00 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 5601 

Fishers Lane, Rockville, MD 20892 

(Telephone Conference Call). 

Contact Person: Frank S. De Silva, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

Room #3E72A, National Institutes of Health/ 

NIAID, 5601 Fishers Lane, MSC 9823, 

Rockville, MD 20892–9823, (240) 669–5023, 

fdesilva@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: July 25, 2018. 

Natasha M. Copeland, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2018–16297 Filed 7–30–18; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Coast Guard 

[Docket No. USCG–2018–0492] 

Great Lakes Pilotage Advisory 

Committee; Vacancy 

AGENCY: U.S. Coast Guard, Department 

of Homeland Security. 

ACTION: Request for applications; 

extension of application. 

SUMMARY: The U.S. Coast Guard seeks 

applications for membership on the 

Great Lakes Pilotage Advisory 

Committee. The Great Lakes Pilotage 

Advisory Committee provides advice 

and makes recommendations to the 

Secretary of Homeland Security through 

the U.S. Coast Guard Commandant on 

matters relating to Great Lakes pilotage, 

including review of proposed Great 

Lakes pilotage regulations and policies. 

DATES: Open until the vacancy is filled. 

ADDRESSES: Applicants should send a 

cover letter expressing interest in an 

appointment to the Great Lakes Pilotage 

Advisory Committee that also identifies 

which membership category the 

applicant is applying under, along with 

a resume detailing the applicant’s 

experience via one of the following 

methods: 

• By Email: Rajiv.Khandpur@

uscg.mil. 

• By Fax: (202) 372–8387 ATTN: Mr. 

Rajiv Khandpur. 

• By Mail: Commandant (CG–WWM– 

2), U.S. Coast Guard. 

Attention: Mr. Rajiv Khandpur, 

Designated Federal Officer, Great Lakes 

Pilotage Advisory Committee, 2703 

Martin Luther King Jr. Ave. SE, Stop 

7509, Washington, DC 20593–7509. 

FOR FURTHER INFORMATION CONTACT: Mr. 

Rajiv Khandpur, Designated Federal 

Officer, Great Lakes Pilotage Advisory 

Committee, 2703 Martin Luther King Jr. 

Ave. SE, Stop 7509, Washington, DC 

20593–7509; telephone 202–372–1525, 

fax 202–372–8387, or email at 

Rajiv.Khandpur@uscg.mil. 

SUPPLEMENTARY INFORMATION: On March 

28, 2018, the U.S. Coast Guard 

published a request in the Federal 

Register Volume 83, Number 60, for 

applications for membership in the 

Great Lakes Pilotage Advisory 

Committee. The application in the 

notice is being extended until the 

vacancy is filled. Applicants who 

responded to the initial notice do not 

need to reapply. 

The Great Lakes Pilotage Advisory 

Committee is a federal advisory 

committee established in accordance 

with the provisions of the Federal 

Advisory Committee Act (5 U.S.C., 

Appendix). The Great Lakes Pilotage 

Advisory Committee operates under the 

authority of 46 U.S.C. 9307, and makes 

recommendations to the Secretary and 

the U.S. Coast Guard on matters relating 

to the Great Lakes. 

Meetings of the Great Lakes Pilotage 

Advisory Committee will be held with 

the approval of the Designated Federal 

Officer. The Committee is required to 

meet at least once per year. Additional 

meetings may be held at the request of 

a majority of the Committee or at the 

discretion of the Designated Federal 

Officer. 

Each Great Lakes Pilotage Advisory 

Committee member serves a term of 

office of up to 3 years. Members may 

serve a maximum of six consecutive 

years. All members serve without 

compensation from the Federal 

Government; however, they may receive 

travel reimbursement and per diem. 

We will consider applicants for one 

position that will become vacant on 

September 30, 2018. 

• One member with a background in 

finance or accounting, who— 

a. Must have been recommended to 

the Secretary of the Department of 

Homeland Security by a unanimous 

vote of the other members of the 

Committee, and 

b. May be appointed without regard to 

the requirement that each member have 

five years of practical experience in 

maritime operations. 


daltland on DSKBBV9HB2PROD with NOTICES